Project Grant HT94252510630
Award Date 9/1/25
Completion Date 8/31/29
Dollars Obligated $4M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
San Diego, CA 92131, USA
Similar Awards
- This Project Grant award, totaling $10,009,861.88, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports two primary activities: A randomized controlled multisite trial evaluating a portable near-infrared hematoma imager for the detection of intracranial hemorrhage in acute care settings. This trial will evaluate the efficacy and feasibility of this medical imaging device. A randomized controlled multisite trial...
- This federal Project Grant award of $905,863.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Illinois in Chicago. The award supports advanced biomedical research aimed at understanding the role of neuroactive steroids and dynamic GABAA receptor reconfiguration in postpartum depression. The 4-year project, running from May 1, 2025 to April 30, 2029, will contribute to transforming healthcare for military...
- This $3,800,334 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund The Regents of the University of Colorado to conduct research to improve maternal mental health in military-affiliated pregnant women through the effectiveness of a smart bassinet intervention. The project will run from June 2024 to June 2028 and aims to develop and evaluate an innovative technological solution to address mental health...
- The Defense Health Agency awarded a $2,463,953 Project Grant to Biosensics LLC for the development of a "Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum." The award, made under the Military Medical Research and Development program (CFDA 12.420), will fund the creation of innovative wearable sensor technologies and cloud-based software solutions to enable remote monitoring and management of frontotemporal dementia and related...
- This federal Project Grant award for $1,607,403.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a longitudinal study on monitoring cognitive changes in older veterans using telehealth-based computerized neuropsychological assessments. The award was granted to the East Bay Institute for Research & Education Inc., a non-profit organization in Mather, California, to conduct this 3-year research project from March 1,...
- The U.S. Defense Health Agency awarded a $1,399,917 Project Grant to Ndri-Usa Inc., a non-profit organization based in New York City, under the Military Medical Research and Development program (CFDA 12.420). This 4-year grant, effective April 1, 2025 through March 31, 2029, will support the development of a digital approach to personalizing care, reducing stress, and increasing support for veterans with dementia and their caregivers. Ndri-Usa Inc. has established expertise in conducting...
- This federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), is for a prospective randomized study of a novel EEG neurofeedback system for the treatment of PTSD using machine learning-based amygdala biomarkers. The total funding amount is $3,966,794.00, with a performance period from September 1, 2024 to August 31, 2027. The awardee, Foundation For Atlanta Veterans Education And Research, Inc., is a non-profit...
- The U.S. Department of Defense's Defense Health Agency awarded a $323,538 Project Grant to The Johns Hopkins University to conduct research on "The Role of Autophagy in the Etiology of Postpartum Depression." This grant, provided under the Military Medical Research and Development CFDA program (12.420), supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public through innovative and impactful research. The funding...
- The Department of the Army Medical Command, through the Military Medical Research and Development (CFDA 12.420) federal grant program, awarded Encephalogix, Inc. a $459,994 Project Grant to support epilepsy research. The award, effective from Sep 1, 2024 to Aug 31, 2025, will fund the company's "Epilepsy Research Program Idea Development Award" to explore innovative approaches to the prevention, diagnosis, treatment, and management of epilepsy, a condition relevant to military...
- This federal Project Grant award of $1,645,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is for a research project titled "TREATING HER2 THERAPY-RESISTANT BRAIN METASTASIS USING ANTIDEPRESSANTS." The award was granted to The Trustees of Columbia University in the City of New York, Health Sciences Division, and runs from Jul 1, 2025 to Jun 30, 2028. The project aims to conduct advanced biomedical research to investigate the use...
This federal Project Grant award of $4,032,394.00, issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), will fund a 4-year prospective validation study of the Enlighten Device in predicting postpartum depression. The award recipient, Dionysus Digital Health Inc. (UEI: S8GZCMJ3NGM4), will conduct the study using at-home blood and saliva sample collection in San Diego, CA. The study aims to validate the Enlighten Device's ability to predict postpartum depression, which has the potential to transform healthcare for military service members, veterans, and the broader public. The award period runs from Sep 1, 2025 through Aug 31, 2029.
Generated 10/21/25, 6:06 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $4.0m | 8/18/25 |